SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

DSM eyes generic omega-3 drug space with €420m ONC buy

By Shane Starling , 18-May-2012
Last updated on 18-May-2012 at 19:12 GMT2012-05-18T19:12:25Z

ONC is strong in omega-3 supplements, but could drug apps hold greater promise?
ONC is strong in omega-3 supplements, but could drug apps hold greater promise?

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

DSM board member Stephan Tanda told us the drug route was largely unexplored as ONC does little business in that space, but events were conspiring in its favour as GlaxoSmithKline’s blockbuster lipid regulator, Lovaza, is set to go off patent later this year.

“So there is the option to participate in the generic drug space, but this market is yet to be developed, so it remains an option,” Tanda said, noting that did not detract from DSM’s ambition to, “accelerate penetration” into European and emerging food and supplement markets.

“We chose ONC because they are the biggest fish-sourced, omega-3 oil supplier in the world.”

The C$540m (€420m) move for ONC comes less than two years after the Dutch company paid about €800m for algae-sourced DHA omega-3 leader, Martek Biosciences. Martek has contributed significantly to DSM Nutritional Products revenues and profits, and has benefitted from distribution and marketing synergies under DSM’s new Nutritional Lipids division that will also house ONC.

The two complement each other, Tanda said, with Martek’s infant food orientation and ONC’s greater strength in supplements and foods with its DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) forms.

DHA and EPA are most strongly linked to brain, heart and eye benefits in the scientific literature and have won health claims off the back of that in various markets including Europe and North America.

The deal gives DSM a stronghold in the North American dietary supplements market, while gaining access to ONC’s Powder-loc omega-3 manufacturing technologies that can be transferred to other parts of its portfolio.

It is DSM’s fifth acquisition since it announced in 2010 its shift from being a fine chemicals player with a line in nutrients to a more focused life sciences company, and it has made no secret of its ongoing ambition (and funds) to buy in more nutritional firms and processes.

Bolt-on growth

One analyst told Reuters the move was in line with DSM acquisition strategies and should deliver healthy margins.

"Doing more add-on acquisitions in nutrition makes sense for DSM. Smaller deals such as this are easier to integrate and it being non-listed results in DSM paying a reasonable multiple for such a high-margin business," said ING analyst Fabian Smeets.

"There is a strategic fit, there should be growth opportunities, and the deal is EPS (earnings per share) accretive ... in 2013 already."

ONC forecast sales of about C$190m (€147m) for 2012 with EBITDA earnings up to C$60m (€46m). The business has grown by about 20% per year for the past five years buoyed by bulging US supplement sales and growing numbers of functional foods using its MEG-3 branded ingredient.

Feike Sijbesma, CEO and chairman of the DSM Managing Board, said in a statement: "After our successful acquisition of Martek in 2011, the acquisition of Ocean Nutrition Canada is the logical next step in developing our Nutritional Lipids into a major growth platform for our Nutrition cluster.”

It recently celebrated selling 100 billion servings of the ingredient.

15-year-old Ocean Nutrition Canada employs 415 people and has production facilities in Canada, the US and Peru.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars